| CTRI Number |
CTRI/2025/02/080754 [Registered on: 18/02/2025] Trial Registered Prospectively |
| Last Modified On: |
10/02/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda Other (Specify) [Therapeutic] |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Efficacy of mustadi ghanvati with and without udvartana in hyperlipidemia on lipid profile |
|
Scientific Title of Study
|
Randomized Controlled Trial of Efficacy of Mustadi Ghanvati With and Without Udvartana in Medoroga With Special Reference to Hyperlipidemia on Lipid Profile |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Mayuri Madhukar Mungale |
| Designation |
PG Scholar |
| Affiliation |
Government Ayurved College and Hospital, Nagpur |
| Address |
Department of Kayachikitsa OPD no 1, Government Ayurved College
and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra
440024 India Department of Kayachikitsa OPD no 1, Government Ayurved College
and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra
440024 India Nagpur MAHARASHTRA 440024 India |
| Phone |
8378889923 |
| Fax |
|
| Email |
mayurimungale1998@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Ashish Thatere |
| Designation |
Assistant Professor |
| Affiliation |
Government Ayurved College and Hospital, Nagpur |
| Address |
Department of Kayachikitsa OPD no 1, Government Ayurved College
and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra
440024 India Department of Kayachikitsa OPD no 1, Government Ayurved College
and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra
440024 India Nagpur MAHARASHTRA 440024 India |
| Phone |
9423406821 |
| Fax |
|
| Email |
ashish.thatere@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Mayuri Madhukar Mungale |
| Designation |
PG Scholar |
| Affiliation |
Government Ayurved College and Hospital, Nagpur |
| Address |
Department of Kayachikitsa OPD no 1, Government Ayurved College
and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra
440024 India Department of Kayachikitsa OPD no 1, Government Ayurved College
and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra
440024 India Nagpur MAHARASHTRA 440024 India |
| Phone |
8378889923 |
| Fax |
|
| Email |
mayurimungale1998@gmail.com |
|
|
Source of Monetary or Material Support
|
| Government Ayurveda College and Hospital, Raje Raghuji Nagar, Sakkardara Square, Nagpur
440024 |
|
|
Primary Sponsor
|
| Name |
Government Ayurveda College and Hospital, Nagpur |
| Address |
Government Ayurved College
and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra
440024 India
Nagpur |
| Type of Sponsor |
Other [Government Ayurved College and Hospital] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Mayuri Madhukar Mungale |
Government Ayurved College and Hospital Nagpur |
Department of Kayachikitsa OPD no 1, Government Ayurved College
and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra
440024 India Nagpur MAHARASHTRA |
8378889923
mayurimungale1998@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee Government Ayurved College,Nagpur |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:E785||Hyperlipidemia, unspecified. Ayurveda Condition: MEDOROGAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Procedure | - | udvartanam, उद्वर्तनम् | (Procedure Reference: Kale V. S. Charak Samhita, Chaukhambha Sanskrit pratishthan, 2016, Sutraasthana, Adhyay no. 21/21, page.no.325, Procedure details: Purvakarma Bladder & bowel should be emptied. Patient is asked to lie-down on Abhyanga table with minimum cloths. Pradhana Karma Udavartana will be done with mustadi Churna. Churna will be applied to whole body in upward direction and opposite to hair root. Udvartana should begin from legs arms chest abdomen and back and gluteal region. Udvartana should be done in a clockwise and anticlockwise motion over the joints chest palms soles of the feet. Time At morning before bath. Dose As per requirement for 20 min. Duration 30 days. Paschata Karma After udvartana patient will be wiped with sterile cloth and asked to take rest for 15 minutes. Patient will be asked to take sukhoshnajala snana.) (1) Medicine Name: Mustadi Ghanvati, Reference: Kale V. S. Charak Samhita, Chaukhambha Sanskrit pratishthan, 2016, Sutraasthana, Adhyay no. 23/12-14, page.no.325, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 1(g), Frequency: tds, Duration: 30 Days | | 2 | Comparator Arm | Drug | Classical | | (1) Medicine Name: Mustadi Ghanvati, Reference: Kale V. S. Charak Samhita, Chaukhambha Sanskrit pratishthan, 2016, Sutraasthana, Adhyay no. 23/12-14, page.no.325, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1(g), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Koshnajala), Additional Information: Charak asserted that all santarpanjanya vyadhis or overnutrition-related disorders could be cured with regular use of mustadi kwath. For improved efficacy and patient compliance the traditional mustadi kwath was changed and transformed into a ghanvati form |
|
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
Patients who are willing to participate in trial and ready to give written consent.Patient having minimum fifty percent symptoms of medoroga according to classics and fulfilling diagnostic criteria of this study.Male and females, aged between twenty to seventy years irrespective of caste religion socioeconomic and educational status.Patient whose lipid profile shows any one or both of the following diagnostic criteria of hyperlipidemia that is serum cholesterol 201 mg per dl upto 1000 mg per dl, Serum Triglycerides 151 mg per dl upto 1000 mg per dl will be selected.Patients of Medoroga having BMI more than 25 Kg per m2 and less than 40 Kg per m2.Patient with controlled HTN BP Systolic less than 150 and Diastolic less than 100 mmHg and DM having FBS less than 150 mg per dl and PMBS less than 250 mg per dl.Patient who had not participated in any research work since last six months will be included
|
|
| ExclusionCriteria |
| Details |
Patients who are not willing to participate in trial and not ready to give written consent. Patients having age below 20 years and above 70 years.Patients who have uncontrolled HTN BP Systolic greater than 150 and Diastolic greater than 100 mmHg. Patients who have uncontrolled DM FBS greater than 150 mg per dl and PMBS greater than 250 mg per dl.Patients having history of serious cardiac disorders like myocardial infarction cardiac failure etc. and any other serious renal hepatic respiratory diseases etc. will also be excluded.Patients having a history of untreated thyroid disorders.Patients who are unfit for udvartana like skin disorders injury or wound hypersensitive.Drug induced hyperlipidemia like glucocorticoids induced hyperlipidemia.Pregnant females and lactating mothers.Who are currently participating in any other clinical trial from last 6 month. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
To evaluate the efficacy of Mustadi Ghanvati with and without Udvartana in
the management of Medoroga w.s.r.t. hyperlipidemia on lipid profile.
To evaluate the efficacy of Mustadi Ghanvati with and without Udvartana in
management of Medoroga w.s.r.t. hyperlipidaemia on symptom scale of
Medoroga.
To evaluate the efficacy of Mustadi Ghanvati with and without Udvartana in
management of Medoroga w.s.r.t. hyperlipidaemia on anthropometric parameters. |
On 0th day, 16th day, 31st day
of trial |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
To review and study literature of Medoroga as per Ayurvedic classics.
To review and study literature of hyperlipidaemia as per modern science |
On 0th day, 16th day, 31st day
of trial |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
01/03/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Plan of work After Institutional Ethics Clearance of Government Ayurved College, Nagpur Screening of Population will be done from Patients in OPD, IPD of our hospital attached to institute. In the Clinical study 60 Patients of Medoroga with Hyperlipidemia will include. Assessment of lipid profile and clinical symptoms of Medoroga will be done. If patient fulfill the criteria of inclusion, subject would also give freedom to ask the questions and all questions would answer. If he/she agrees for participation in the study and found fit to include then that patient will be included in a study. The treatment will be given to patient as follows: Group A (Trial Group) 1) 0 Day assessment (Before treatment) on recruitment day 2) Udvartana with Mustadi Churna At morning before bath for 20 mins daily (for 15 days) + Mustadi Ghanvati 500 mg 2 TID (3 g/day) With Lukewarm water Before meal (for 15 days) 3) Mid treatment assessment (on 16th day) Udvartana with Mustadi Churna At morning before bath for 20 mins daily (for next 15 days) + Mustadi Ghanvati 500 mg 2 TID (3 g/day) With Lukewarm water Before meal For next 15 days 4) Assessment after completion of treatment (On 31st day) Group B(Control Group) 1)0 Day assessment (Before treatment) on recruitment day 2)Mustadi Ghanvati 500 mg 2 TID (3 g/day) With Lukewarm water Before meal (for 15 days) 3)Mid treatment assessment (on 16th day) 4)Mustadi Ghanvati 500 mg 2 TID (3 g/day) With Lukewarm water Before meal (For next 15 days) 5)Assessment after completion of treatment (On 31st day) Medium of Dissertation: The dissertation will be written in English by using Ayurvedic terminology where ever necessary in Sanskrit. Study Setting: OPD and IPD of hospital attached to institute. Study Design: Randomized Controlled Trial Duration of study: 18 months Duration of Treatment: 30 days Ethical Clearance: Clearance from Institutional Ethics committee of our Institute Study Population: All obese patients attending OPD, IPD of our institute will be considered in this study. Patients in between age group of 20 – 70 years. Patient will be diagnosed on the basis of lipid profile and symptoms of Medoroga according to Ayurvedic Classics. Sample Size: Sample size was calculated with the help of data published by Nadkarni MA, Vyas SN, Baghel MS, Ravishankar B. Randomized placebo-controlled trial of Mustadi Ghanavati in hyperlipidaemia. Required Sample Size per group is 26 Considering 10% dropout/non-response, Hence Final Sample Size in each group is 30. Physical characters will be assessed on the basis of following Questionnaires and Scales: A) OBJECTIVE CRITERIA: 1] ANTHROPOMETRIC CHARACTERS 1.Height 2.Weight 3.BMI 4.Abdominal circumference 5.Waist circumference 6.Hip circumference 7.Waist Hip Ratio 8.Skinfold Thickness - a. Abdominal b. Bicep c. Triceps 2] CLINICAL PARAMETERS: 1.SPO2 2.Pulse Rate 3.Respiration Rate 4.Blood Pressure 5. Temperature 3] BIOCHEMICAL PARAMETERS: 1. Lipid profile 2. Blood sugar level fasting and Post Prandial 3. Complete blood count 4. Erythrocytes sedimentation rate 5. Urine routine and microscopic B) OBJECTIVE CRITERIA: 1] Symptoms of Medoroga 2] Lipid Profile 3] BMI 4] Waist hip ratio, abdominal circumference and skin folds (abdominal, biceps & triceps) |